[PDF][PDF] Current therapeutic strategy in Alzheimer's disease

S Singh, AS Kushwah, R Singh… - Eur Rev Med …, 2012 - europeanreview.org
Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disorder that places
a substantial burden on patients, their families, and society. Alzheimer's disease (AD) is the …

Therapeutic approaches for the treatment of Alzheimer's disease: an overview

LF Lau, MA Brodney - Alzheimer's Disease, 2008 - Springer
Alzheimer's disease (AD) is a neurodegenerative disease that robs the minds of our elderly
population. Approximately one in every eight adults over the age of 65 and nearly half of …

Challenges in the treatment of Alzheimer's disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors

YC Kuo, R Rajesh - Expert review of neurotherapeutics, 2019 - Taylor & Francis
Introduction: Alzheimer's disease (AD), a commonly encountered neurodegenerative
disorder, causes cognitive decline and has a devastating effect on the quality of life. AD …

Disease-modifying therapies in Alzheimer's disease

S Salloway, J Mintzer, MF Weiner, JL Cummings - Alzheimer's & dementia, 2008 - Elsevier
Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disorder that places
a substantial burden on patients, their families, and society. The disease affects …

[HTML][HTML] Progress in the development of new drugs in Alzheimer's disease

A Piau, F Nourhashémi, C Hein, C Caillaud… - The Journal of nutrition …, 2011 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …

Therapeutic approaches to Alzheimer's disease

HW Klafki, M Staufenbiel, J Kornhuber, J Wiltfang - Brain, 2006 - academic.oup.com
Alzheimer's disease is an age-related progressive neurodegenerative disorder with an
enormous unmet medical need. It is the most common form of dementia affecting∼ 5% of …

[HTML][HTML] Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau

Y Hong-Qi, S Zhi-Kun, C Sheng-Di - Translational neurodegeneration, 2012 - Springer
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mainly the memory
and cognitive function in elderly. Extracellular beta amyloid deposition and intracellular tau …

Drug treatments in development for Alzheimer's disease

MC Woodward - Journal of Pharmacy Practice and Research, 2012 - Wiley Online Library
New therapies are needed to combat the symptoms and underlying disease processes in
the dementias. A rapid increase in our understanding of the risk factors for dementia and the …

Novel disease-modifying therapies for Alzheimer's disease

T Jiang, JT Yu, L Tan - Journal of Alzheimer's disease, 2012 - content.iospress.com
Alzheimer's disease (AD) is the most common progressive dementia in the elderly and
places an enormous burden on the individual and society. Presently, the treatments for AD …

[HTML][HTML] Impact of new drugs for therapeutic intervention in Alzheimer's disease

J Olloquequi, M Ettcheto, A Cano… - Frontiers in Bioscience …, 2022 - imrpress.com
The increases in population ageing and growth are leading to a boosting in the number of
people living with dementia, Alzheimer's disease (AD) being the most common cause. In …